DataBiologics Featured Article on OrthoBiologics
Thanks to DataBiologics for featuring an article about my work in OrthoBiologics, cell-based "stem cell" therapy and PRP treatments.
A Biologic Alternative for ACL Repair
Video 1: https://youtu.be/wQEeeCrzFGE
Typical ski - associated proximal ACL tear at ~10 days.
"Needle" arthroscopic view, after MRI confirmation.
Note the hemarthrosis/healing environment, preserved by the closed Nanoscope technique, and the generally well-aligned ligament (except for the partial PL flap).
Middle-aged female, occasional recreational athlete, strongly desired "conservative" care.Video 2: https://youtu.be/aaviAHjYEm0
BMC injected with an 18 ga spinal needle into multiple proximal ligament attachment sites. Note the "closed" Nanoscope system (without outflow), capturing both intra-ligament and intra-articular BMC/PPP products.
Patient is immobilized in slight flexion/allowed gentle PROM and protected weight-bearing for 3 weeks.
Firm endpoint at 6 wks.
Is this a new "healing response" algorithm for proximal/partial ACL tears?Kelly Cunningham MDAustin OrthoBiologicsBoard-certified orthopedic surgeonFellowship trained sports medicine Arthroscopy and regenerative medicine specialistPRP and cellular "stem cell" therapyaustinorthobio.com
Orthopedic regenerative sports medicine: info@austinorthobio.com
Dr. Kelly Cunningham; Board Certified Orthopedic Surgeon
You Might Also Enjoy...
Can I avoid surgery with Biologics?
Dr. Cunningham discusses the usages of surgical treatments with biologics.
Shoulder Treatments with OrthoBiologics
Dr Kelly Cunningham discusses shoulder treatments with OrthoBiologics, PRP and cell-based ("stem cell")
Top Performer Award
Dr Cunningham has been presented a Top Performer award from DataBiologics.
Outcomes of PRP and Stem Cell Treatments
Dr Cunningham discusses the expected outcomes of PRP and Stem Cell Treatments
A lot of confusion over biologic "birth products" and exosomes — Austin OrthoBiologics explains
Perhaps due to recent changes to FDA leadership with the new administration, there seems to be renewed interest in birth products, such as cord blood, placental tissue and Wharton's jelly, and their potential as orthobiologic treatments. Let's dive in...